Global Proteomics | Next-Generation Proteomics | Proteomic Solutions

Powering precision medicine into reality

The decoding of the proteome is revolutionizing the way diseases are diagnosed, treated, and prevented. Biognosys invents and provides patented proteomics solutions at the quality, scale, and speed required to transform R&D, clinical trials, and clinical decision making.

OUR STORY

Transformative Insights from Discovery to Clinic

Unbiased biological insights from tissue and biofluids

Novel drug target identification and validation

Custom panels for absolute protein quantification

Biognosys is the world leader in next-generation proteomics contract research services to support pharma and biotech research and clinical development.

OUR SERVICES

High Performance Software, Peptide Kits, and Sample Preparation Reagents

Our software solutions for proteomics include Spectronaut® for DIA proteomics, SpectroDive™ for Targeted Proteomics, SpectroMine™ for DDA proteomics, and our free-of-charge QC tool QuiC™.

 

 

OUR SOFTWARE

Our peptide kits and reagents empower researchers to apply cutting-edge proteomics in-house. Discover our PQ500™ Reference Peptides for plasma proteomics quantification, our iRT kit for quality control, and our sample preparations kits.

 

OUR KITS

Latest News & Stories

News
Biognosys Enters Reselling Agreement for Spectronaut Proteomics Software with Leading Provider of Mass Spectrometry Systems

READ MORE
News
Biognosys Announces Commercial Availability of NULISA™ Proteomics Assay Services for Biomarker Research

[...]

READ MORE
Resource - Launch Pages
Spectronaut® 19: Unlock Your Data’s True Story

Spectronaut® 19 goes above and beyond to bring you more biologically relevant targets than before, and solutions that make large-scale proteomics analysis a breeze. This new[...]

READ MORE
News
Biognosys Launches Spectronaut 19 and Presents Advances with Its Research Platforms at the ASMS 2024 Annual Conference

[...]

READ MORE
News
Biognosys Launches Groundbreaking P2 Plasma Enrichment Technology for Unbiased, Deep Plasma Proteomics at ASMS 2024

[...]

READ MORE
News
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research

Strategic partnership expands Biognosys’ services to include Alamar’s NULISA assays as well as joint scientific research in biofluid-based proteomics [...]

READ MORE
News
Biognosys Unveils Enhanced Plasma Proteomics Services for Deep and High-Throughput Biomarker Discovery

The new workflows leverage an innovative plasma enrichment method, delivering deep proteome coverage with exceptional data quality, reproducibility, and efficiency. The platform[...]

READ MORE
News
Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts

The new lab facility in Newton, Massachusetts ensures closer proximity to US customers and provides domestic access to select CRO services for discovery proteomics. Biognosys’[...]

READ MORE
News
Biognosys Introduces Higher-Throughput Discovery Proteomics Research Services Based on the Bruker timsTOF Platform

Biognosys, a leader in next-generation proteomics solutions for biomarker discovery and drug development, today announced a significant enhancement to its portfolio of discovery[...]

READ MORE
News
Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers

New strategic partnership aims to broaden access to Biognosys’ leading CRO services and Spectronaut® software tools for unbiased proteomics and epiproteomics, expected to[...]

READ MORE

Our technological innovation and scientific expertise are fueled by an extensive network of over 25 collaborators across the life science industry and academia.

 

Our Collaborators

Join Email List

    By selecting any or all of the topic preferences below, you agree to receive respective information from Biognosys via email. You can unsubscribe from these communications at any time. By submitting this form, you confirm that you consent to Biognosys processing of your personal data for the purposes and in the manner as described in our Privacy Notice.

    Join the Biognosys email list to receive news and exclusive content.

    Join Email List

      By selecting any or all of the topic preferences below, you agree to receive respective information from Biognosys via email. You can unsubscribe from these communications at any time. By submitting this form, you confirm that you consent to Biognosys processing of your personal data for the purposes and in the manner as described in our Privacy Notice.

      Contact

        Close banner

        New: Spectronaut® 19

        Unlock Your Data's True Story

        New: Spectronaut® 19

        Unlock Your Data's True Story

        Learn More